Literature DB >> 20424172

Caspase-3 cleaves specific 19 S proteasome subunits in skeletal muscle stimulating proteasome activity.

Xiaonan H Wang1, Liping Zhang, William E Mitch, Joseph M LeDoux, Junping Hu, Jie Du.   

Abstract

With muscle wasting, caspase-3 activation and the ubiquitin-proteasome system act synergistically to increase the degradation of muscle proteins. Whether proteasome activity is also elevated in response to catabolic conditions is unknown. We find that caspase-3 increases proteasome activity in myotubes but not in myoblasts. This difference is related to the cleavage of specific 19 S proteasome subunits. In mouse muscle or myotubes, caspase-3 cleaves Rpt2 and Rpt6 increasing proteasome activity. In myoblasts, caspase-3 cleaves Rpt5 to decrease proteasome activity. To confirm the caspase-3 dependence, caspase-3 cleavage sites in Rpt2, Rpt6, or Rpt5 were mutated. This prevented the cleavage of these subunits by caspase-3 as well as the changes in proteasome activity. During differentiation of myoblasts to myotubes, there is an obligatory, transient increase in caspase-3 activity, accompanied by a corresponding increase in proteasome activity and cleavage of Rpt2 and Rpt6. Therefore, differentiation changes the proteasome type from sensitivity of Rpt5 to caspase-3 in myoblasts to sensitivity of Rpt2 and Rpt6 in myotubes. This novel mechanism identifies a feed-forward amplification that augments muscle proteolysis in catabolic conditions. Indeed, we found that in mice with a muscle wasting condition, chronic kidney disease, there was cleavage of subunits Rpt2 and Rpt6 and stimulation of proteasome activity.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20424172      PMCID: PMC2898444          DOI: 10.1074/jbc.M109.041707

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  46 in total

1.  Enac degradation in A6 cells by the ubiquitin-proteosome proteolytic pathway.

Authors:  B Malik; L Schlanger; O Al-Khalili; H F Bao; G Yue; S R Price; W E Mitch; D C Eaton
Journal:  J Biol Chem       Date:  2001-01-26       Impact factor: 5.157

Review 2.  The ubiquitin-proteasome proteolytic pathway: destruction for the sake of construction.

Authors:  Michael H Glickman; Aaron Ciechanover
Journal:  Physiol Rev       Date:  2002-04       Impact factor: 37.312

3.  Role of Rpn11 metalloprotease in deubiquitination and degradation by the 26S proteasome.

Authors:  Rati Verma; L Aravind; Robert Oania; W Hayes McDonald; John R Yates; Eugene V Koonin; Raymond J Deshaies
Journal:  Science       Date:  2002-08-15       Impact factor: 47.728

Review 4.  Protein degradation and the generation of MHC class I-presented peptides.

Authors:  Kenneth L Rock; Ian A York; Tomo Saric; Alfred L Goldberg
Journal:  Adv Immunol       Date:  2002       Impact factor: 3.543

5.  Activation of caspase-3 is an initial step triggering accelerated muscle proteolysis in catabolic conditions.

Authors:  Jie Du; Xiaonan Wang; Christiane Miereles; James L Bailey; Richard Debigare; Bin Zheng; S Russ Price; William E Mitch
Journal:  J Clin Invest       Date:  2004-01       Impact factor: 14.808

Review 6.  The importance of the proteasome and subsequent proteolytic steps in the generation of antigenic peptides.

Authors:  Alfred L Goldberg; Paolo Cascio; Tomo Saric; Kenneth L Rock
Journal:  Mol Immunol       Date:  2002-10       Impact factor: 4.407

7.  Identification of ubiquitin ligases required for skeletal muscle atrophy.

Authors:  S C Bodine; E Latres; S Baumhueter; V K Lai; L Nunez; B A Clarke; W T Poueymirou; F J Panaro; E Na; K Dharmarajan; Z Q Pan; D M Valenzuela; T M DeChiara; T N Stitt; G D Yancopoulos; D J Glass
Journal:  Science       Date:  2001-10-25       Impact factor: 47.728

8.  Ubiquitinated proteins activate the proteasome by binding to Usp14/Ubp6, which causes 20S gate opening.

Authors:  Andreas Peth; Henrike C Besche; Alfred L Goldberg
Journal:  Mol Cell       Date:  2009-12-11       Impact factor: 17.970

9.  Caspase 3 activity is required for skeletal muscle differentiation.

Authors:  Pasan Fernando; John F Kelly; Kim Balazsi; Ruth S Slack; Lynn A Megeney
Journal:  Proc Natl Acad Sci U S A       Date:  2002-08-12       Impact factor: 11.205

10.  Multiple types of skeletal muscle atrophy involve a common program of changes in gene expression.

Authors:  Stewart H Lecker; R Thomas Jagoe; Alexander Gilbert; Marcelo Gomes; Vickie Baracos; James Bailey; S Russ Price; William E Mitch; Alfred L Goldberg
Journal:  FASEB J       Date:  2004-01       Impact factor: 5.191

View more
  42 in total

Review 1.  Post-translational modification of cardiac proteasomes: functional delineation enabled by proteomics.

Authors:  Sarah B Scruggs; Nobel C Zong; Ding Wang; Enrico Stefani; Peipei Ping
Journal:  Am J Physiol Heart Circ Physiol       Date:  2012-04-20       Impact factor: 4.733

2.  Pharmacological inhibition of myostatin suppresses systemic inflammation and muscle atrophy in mice with chronic kidney disease.

Authors:  Liping Zhang; Vik Rajan; Eugene Lin; Zhaoyong Hu; H Q Han; Xiaolan Zhou; Yanping Song; Hosung Min; Xiaonan Wang; Jie Du; William E Mitch
Journal:  FASEB J       Date:  2011-01-31       Impact factor: 5.191

3.  MicroRNA-23a and MicroRNA-27a Mimic Exercise by Ameliorating CKD-Induced Muscle Atrophy.

Authors:  Bin Wang; Cong Zhang; Aiqing Zhang; Hui Cai; S Russ Price; Xiaonan H Wang
Journal:  J Am Soc Nephrol       Date:  2017-04-11       Impact factor: 10.121

Review 4.  Proteolysis in illness-associated skeletal muscle atrophy: from pathways to networks.

Authors:  Simon S Wing; Stewart H Lecker; R Thomas Jagoe
Journal:  Crit Rev Clin Lab Sci       Date:  2011-06-24       Impact factor: 6.250

Review 5.  Mechanisms of muscle wasting in chronic kidney disease.

Authors:  Xiaonan H Wang; William E Mitch
Journal:  Nat Rev Nephrol       Date:  2014-07-01       Impact factor: 28.314

Review 6.  Exercise and the control of muscle mass in human.

Authors:  Marc Francaux; Louise Deldicque
Journal:  Pflugers Arch       Date:  2018-10-11       Impact factor: 3.657

7.  Regulation of feedback between protein kinase A and the proteasome system worsens Huntington's disease.

Authors:  Jiun-Tsai Lin; Wei-Cheng Chang; Hui-Mei Chen; Hsing-Lin Lai; Chih-Yeh Chen; Mi-Hua Tao; Yijuang Chern
Journal:  Mol Cell Biol       Date:  2012-12-28       Impact factor: 4.272

8.  Stat3 activation links a C/EBPδ to myostatin pathway to stimulate loss of muscle mass.

Authors:  Liping Zhang; Jenny Pan; Yanjun Dong; David J Tweardy; Yanlan Dong; Giacomo Garibotto; William E Mitch
Journal:  Cell Metab       Date:  2013-09-03       Impact factor: 27.287

9.  Uremic metabolites impair skeletal muscle mitochondrial energetics through disruption of the electron transport system and matrix dehydrogenase activity.

Authors:  Trace Thome; Zachary R Salyers; Ravi A Kumar; Dongwoo Hahn; Fabian N Berru; Leonardo F Ferreira; Salvatore T Scali; Terence E Ryan
Journal:  Am J Physiol Cell Physiol       Date:  2019-07-10       Impact factor: 4.249

10.  Autoubiquitination of the 26S proteasome on Rpn13 regulates breakdown of ubiquitin conjugates.

Authors:  Henrike C Besche; Zhe Sha; Nikolay V Kukushkin; Andreas Peth; Eva-Maria Hock; Woong Kim; Steven Gygi; Juan A Gutierrez; Hua Liao; Lawrence Dick; Alfred L Goldberg
Journal:  EMBO J       Date:  2014-05-08       Impact factor: 11.598

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.